Brief: Apellis Pharmaceuticals Q1 Basic EPS USD -0.74
May 07 (Reuters) - Apellis Pharmaceuticals Q1 product revenue USD 149.9 million. Q1 operating expenses USD 250.125 million Q1 net income USD -92.225 million Q1 operating income USD -83.328 million